108 Participants Needed

Expressive Writing Therapy for Cancer Survivors

WT
Overseen ByWilliam Tsai, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: New York University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how expressive writing can aid Chinese American cancer survivors. It compares three methods: expressive helping (expressive writing therapy), expressive writing, and factual writing about cancer experiences. Participants will write for 20 minutes a week about their feelings or facts related to their journey. This trial targets individuals who prefer communicating in Mandarin or Cantonese and have completed their main cancer treatments within the last five years. Those already in active support groups or who have difficulty writing might not be suitable candidates. As an unphased trial, this study provides a unique opportunity to contribute to understanding the benefits of expressive writing for emotional healing.

Will I have to stop taking my current medications?

The trial protocol does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications, especially since the trial includes those still on medication for managing cancer-related symptoms.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that expressive writing therapies, such as Expressive Helping, are generally safe for cancer patients. Studies indicate that these therapies can improve mental health without causing harm. Many studies, for instance, have found that expressive writing helps reduce stress and improve mood in cancer patients.

Expressive Writing, a similar method, has also been well-received in past research. It can enhance quality of life and emotional health without major side effects. These findings suggest that expressive writing provides a safe way for cancer survivors to process their experiences and emotions.

Factual Writing, which involves writing about the facts of one's diagnosis and treatment, differs slightly. While specific safety data for this method is limited, writing therapies overall, including factual writing, are considered low-risk and do not typically cause negative effects.

In summary, past studies support the safety of these writing interventions for cancer survivors. They show promise in improving well-being without adverse events.12345

Why are researchers excited about this trial?

Researchers are excited about Expressive Helping because it offers a fresh approach to emotional and psychological support for cancer survivors. Unlike traditional therapies that might focus on talking or medication, this method combines expressive writing with peer support to enhance emotional healing. Participants engage in writing sessions that encourage them to express their feelings, and later, they share and receive support from peers. This unique blend of self-expression and community support could foster a deeper sense of connection and resilience, potentially improving the overall well-being of cancer survivors in a way that traditional methods might not.

What evidence suggests that this trial's treatments could be effective for cancer survivors?

Research shows that writing about thoughts and feelings can help cancer survivors. Some studies have found that this type of writing can improve the quality of life and health for cancer patients. However, other research suggests it might not be as helpful for those with advanced cancer. In this trial, participants will engage in different writing therapies. One group will try expressive helping, which combines writing with peer support. Although this approach has less research, it is practical and low-cost. Another group will participate in expressive writing, focusing on personal thoughts and feelings. A third group will engage in factual writing, which, though less studied, has been shown to help reduce mental health symptoms and improve self-care. Overall, while some people benefit from these writing therapies, their effectiveness can vary from person to person.12678

Are You a Good Fit for This Trial?

This trial is for Chinese American cancer survivors over 18 who prefer Mandarin or Cantonese and can read/write in Chinese. They should be within 5 years of completing treatment for stage I-III cancer. Those with writing difficulties or active in support groups more than once a week cannot join.

Inclusion Criteria

I am over 18 years old.
I finished my main cancer treatment within the last 5 years or am still on medication for cancer symptoms.
I prefer speaking Mandarin or Cantonese and can read and write in Chinese.

Exclusion Criteria

Difficulties with writing
Current active participation in support groups (i.e., attending more than once per week)

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in writing sessions, including expressive and factual writing, over four weeks

4 weeks
4 sessions (virtual)

Follow-up

Participants are monitored for psychological symptoms and quality of life at multiple intervals post-intervention

6 months
3 follow-up assessments (virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • Expressive Helping
  • Expressive Writing
  • Factual Writing
Trial Overview The study tests the Expressive Helping (EH) intervention's feasibility and effectiveness compared to Expressive Writing and Factual Writing among participants, randomly assigning them to one of these activities.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Expressive HelpingExperimental Treatment1 Intervention
Group II: Expressive WritingActive Control1 Intervention
Group III: Factual WritingActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

New York University

Lead Sponsor

Trials
249
Recruited
229,000+

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Trials
473
Recruited
1,374,000+

Published Research Related to This Trial

The expressive writing (EW) intervention significantly improved women's perceptions of emotional support after treatment for early-stage breast cancer, with participants reporting greater satisfaction compared to the control group.
While EW did not show significant effects on mood, quality of life, or healthcare utilization, most participants found the writing experience valuable and reported no long-term negative effects, suggesting it could be a beneficial and cost-effective addition to cancer care.
Narrowing the gap: the effects of an expressive writing intervention on perceptions of actual and ideal emotional support in women who have completed treatment for early stage breast cancer.Gellaitry, G., Peters, K., Bloomfield, D., et al.[2009]
Expressive writing, involving four 20-minute sessions focused on emotional disclosure, significantly improved the quality of life for breast cancer patients undergoing chemotherapy, with noticeable effects observed two weeks after the intervention.
The study, which included 82 participants, also indicated that expressive writing positively influenced self-care self-efficacy over time, suggesting it is a beneficial and low-cost psychological intervention for patients lacking emotional support.
Effects of Structured Expressive Writing on Quality of Life and Perceived Self-Care Self-Efficacy of Breast Cancer Patients Undergoing Chemotherapy in Central China: A Randomized Controlled Trial.Wang, R., Li, L., Xu, J., et al.[2023]
Expressive writing (EW) interventions showed a small but significant effect in relieving cancer symptoms among 1,718 patients, based on a meta-analysis of 14 trials.
While EW did not significantly improve psychological and cognitive outcomes, it did enhance health-related quality of life compared to usual care, suggesting potential benefits that may require further investigation.
The Effects of Expressive Writing Interventions for Patients With Cancer: A Meta-Analysis.Oh, PJ., Kim, SH.[2017]

Citations

The effect of expressive writing intervention on ...Our results do not support the general effectiveness of EWI in cancer patients and survivors. However, given the practical and inexpensive intervention, it ...
The effects of expressive writing intervention in cancer ...Although the trial results suggest there is no benefit in expressive writing for people with advanced disease the current evidence is limited.
3.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/40686255/
Expressive writing interventions in patients with cancerTwenty-one of the quantitative studies found that EWIs were positively associated with cancer patients' QOL and/or physical health outcomes. Of ...
Using expressive writing to improve cancer caregiver and ...This study examined the feasibility and preliminary efficacy of Expressive Writing (EW) in improving informal cancer caregiver (IC) and patient health.
Expressive Writing in Improving Quality of Life in Patients ...RATIONALE: Expressive writing may help relieve symptoms and improve quality of life in breast cancer survivors with chronic lymphedema. PURPOSE: This clinical ...
Expressive writing interventions in patients with cancerTwenty-one of the quantitative studies found that EWIs were positively associated with cancer patients' QOL and/or physical health outcomes. Of ...
Expressive Writing for Cancer Stress ManagementResearch shows that expressive writing can help cancer patients by reducing distress and improving mood and emotional support perceptions. Studies have found ...
Effects of Structured Expressive Writing on Quality of Life ...This study explored the effectiveness of an expressive writing intervention among patients with breast cancer undergoing chemotherapy in central China.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security